Phase I and Pharmacokinetic study of Satraplatin in children with recurrent or refractory solid tumors, including CNS tumors
Leigh Marcus, M.D., National Cancer Institute Special Project funded 2010-2011 We would like to thank the CBTF for supporting our phase 1 clinical trial of Satraplatin in children with brain tumors. Although overall survival for children with CNS tumors is rising, new agents that are more effective and less toxic are desperately needed. Chemotherapeutic agents …